MicroRNAs may solve the mystery of chronic hepatitis B virus infection

World Journal of Gastroenterology

Volumn 19, Issue 30, 2013, Pages 4867-4876

  Wei, Ying Feng ^a   Cui, Guang Ying ^a   Ye, Ping ^a   Chen, Jia Ning ^a   Diao, Hong Yan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Biomarker; Hepatitis; Hepatitis B; Host virus interaction; MicroRNA; Therapy; Virus

Indexed keywords

ALPHA FETOPROTEIN; ANTAGOMIR; CYCLIN G1; FIBRONECTIN; HEME OXYGENASE 1; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MICRORNA; MICRORNA 101; MICRORNA 122; MICRORNA 125B; MICRORNA 141; MICRORNA 143; MICRORNA 145; MICRORNA 24; MICRORNA 29; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER INJURY; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SURVIVAL; UPREGULATION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 84881512064     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i30.4867     Document Type: Review

References (105)

1. Wang S, Qiu L, Yan X, Jin W, Wang Y, Chen L, Wu E, Ye X, Gao GF, Wang F, Chen Y, Duan Z, Meng S. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1)-modulated P53 activity. Hepatology 2012; 55: 730-741 [PMID: 22105316 DOI: 10.1002/hep.24809]
2. Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 2000; 61: 362-366 [PMID: 10861647]
3. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745 [PMID: 9392700]
4. Zuckerman JN, Zuckerman AJ. Current topics in hepatitis B. J Infect 2000; 41: 130-136 [PMID: 11023756 DOI: 10.1053/ jinf.2000.0720]
5. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005; 34 Suppl 1: S1-S3 [PMID: 16461208 DOI: 10.1016/ S1386-6532(05)00384-7]
6. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2: 395-403 [PMID: 12127351 DOI: 10.1016/S1473-3099(02)00315-8]
7. Bläckberg J, Kidd-Ljunggren K. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol 2000; 33: 992-997 [PMID: 11131464 DOI: 10.1016/S0168-8278(00)80134-8]
8. Chu CM. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 2000; 15 Suppl: E25-E30 [PMID: 10921378 DOI: 10.1046/ j.1440-1746.2000.02097. x]
9. Scaria V, Hariharan M, Pillai B, Maiti S, Brahmachari SK. Host-virus genome interactions: macro roles for microRNAs. Cell Microbiol 2007; 9: 2784-2794 [PMID: 17944962 DOI: 10.1111/j.1462-5822.2007.01050. x]
10. Scaria V, Hariharan M, Maiti S, Pillai B, Brahmachari SK. Host-virus interaction: a new role for microRNAs. Retrovirology 2006; 3: 68 [PMID: 17032463 DOI: 10.1186/1742-4690-3-68]
11. Ghosh Z, Mallick B, Chakrabarti J. Cellular versus viral microRNAs in host-virus interaction. Nucleic Acids Res 2009; 37: 1035-1048 [PMID: 19095692 DOI: 10.1093/nar/gkn1004]
12. Dennis C. The brave new world of RNA. Nature 2002; 418: 122-124 [PMID: 12110860 DOI: 10.1038/418122a]
13. Ambros V. microRNAs: tiny regulators with great potential. Cell 2001; 107: 823-826 [PMID: 11779458]
14. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003; 113: 673-676 [PMID: 12809598]
15. Llave C, Kasschau KD, Rector MA, Carrington JC. Endogenous and silencing-associated small RNAs in plants. Plant Cell 2002; 14: 1605-1619 [PMID: 12119378]
16. Carrington JC, Ambros V. Role of microRNAs in plant and animal development. Science 2003; 301: 336-338 [PMID: 12869753 DOI: 10.1126/science.1085242]
17. Papenfort K, Vogel J. Regulatory RNA in bacterial pathogens. Cell Host Microbe 2010; 8: 116-127 [PMID: 20638647 DOI: 10.1016/j. chom.2010.06.008]
18. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 39: D152-D157 [PMID: 21037258 DOI: 10.1093/ nar/gkq1027]
19. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36: D154-D158 [PMID: 17991681 DOI: 10.1093/nar/gkm952]
20. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34: D140-D144 [PMID: 16381832 DOI: 10.1093/nar/gkj112]
21. Griffiths-Jones S. The microRNA Registry. Nucleic Acids Res 2004; 32: D109-D111 [PMID: 14681370 DOI: 10.1093/nar/ gkh023]
22. Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, Chen X, Dreyfuss G, Eddy SR, Griffiths-Jones S, Marshall M, Matzke M, Ruvkun G, Tuschl T. A uniform system for microRNA annotation. RNA 2003; 9: 277-279 [PMID: 12592000]
23. Meyers BC, Axtell MJ, Bartel B, Bartel DP, Baulcombe D, Bowman JL, Cao X, Carrington JC, Chen X, Green PJ, Griffiths-Jones S, Jacobsen SE, Mallory AC, Martienssen RA, Poethig RS, Qi Y, Vaucheret H, Voinnet O, Watanabe Y, Weigel D, Zhu JK. Criteria for annotation of plant MicroRNAs. Plant Cell 2008; 20: 3186-3190 [PMID: 19074682 DOI: 10.1105/tpc.108.064311]
24. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297 [PMID: 14744438]
25. Cullen BR. Viruses and microRNAs. Nat Genet 2006; 38 Suppl: S25-S30 [PMID: 16736021 DOI: 10.1038/ng1793]
26. Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity 2007; 26: 133-137 [PMID: 17307699 DOI: 10.1016/j. immuni.2007.02.005]
27. Cullen BR. Derivation and function of small interfering RNAs and microRNAs. Virus Res 2004; 102: 3-9 [PMID: 15068874 DOI: 10.1016/j. virusres.2004.01.009]
28. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 597-610 [PMID: 20661255 DOI: 10.1038/nrg2843]
29. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531 [PMID: 15211354 DOI: 10.1038/nrg1379]
30. Baulcombe D. RNA silencing in plants. Nature 2004; 431: 356-363 [PMID: 15372043 DOI: 10.1038/nature02874]
31. Andersson MG, Haasnoot PC, Xu N, Berenjian S, Berkhout B, Akusjärvi G. Suppression of RNA interference by adenovirus virus-associated RNA. J Virol 2005; 79: 9556-9565 [PMID: 16014917 DOI: 10.1128/jvi.79.15.9556-9565.2005]
32. Sano M, Kato Y, Taira K. Sequence-specific interference by small RNAs derived from adenovirus VAI RNA. FEBS Lett 2006; 580: 1553-1564 [PMID: 16472808 DOI: 10.1016/ j. febslet.2006.01.085]
33. Hu W, Wang X, Ding X, Li Y, Zhang X, Xie P, Yang J, Wang S. MicroRNA-141 represses HBV replication by targeting PPARA. PLoS One 2012; 7: e34165 [PMID: 22479552 DOI: 10.1371/journal. pone.0034165]
34. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liverspecific MicroRNA. Science 2005; 309: 1577-1581 [PMID: 16141076 DOI: 10.1126/science.1113329]
35. Banerjee D, Slack F. Control of developmental timing by small temporal RNAs: a paradigm for RNA-mediated regulation of gene expression. Bioessays 2002; 24: 119-129 [PMID: 11835276 DOI: 10.1002/bies.10046]
36. Tang G, Reinhart BJ, Bartel DP, Zamore PD. A biochemical framework for RNA silencing in plants. Genes Dev 2003; 17: 49-63 [PMID: 12514099 DOI: 10.1101/gad.1048103]
37. Rhoades MW, Reinhart BJ, Lim LP, Burge CB, Bartel B, Bartel DP. Prediction of plant microRNA targets. Cell 2002; 110: 513-520 [PMID: 12202040]
38. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355 [PMID: 15372042 DOI: 10.1038/nature02871]
39. Umbach JL, Cullen BR. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev 2009; 23: 1151-1164 [PMID: 19451215 DOI: 10.1101/ gad.1793309]
40. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20 [PMID: 15652477 DOI: 10.1016/j. cell.2004.12.035]
41. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. Combinatorial microRNA target predictions. Nat Genet 2005; 37: 495-500 [PMID: 15806104 DOI: 10.1038/ ng1536]
42. Gottwein E, Cullen BR. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 2008; 3: 375-387 [PMID: 18541214 DOI: 10.1016/ j. chom.2008.05.002]
43. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saïb A, Voinnet O. A cellular microRNA mediates antiviral defense in human cells. Science 2005; 308: 557-560 [PMID: 15845854 DOI: 10.1126/science.1108784]
44. Roberts AP, Jopling CL. Targeting viral infection by microRNA inhibition. Genome Biol 2010; 11: 201 [PMID: 20122293 DOI: 10.1186/gb-2010-11-1-201]
45. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327: 198-201 [PMID: 19965718 DOI: 10.1126/science.1178178]
46. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007; 449: 919-922 [PMID: 17943132 DOI: 10.1038/nature06205]
47. Qiu L, Fan H, Jin W, Zhao B, Wang Y, Ju Y, Chen L, Chen Y, Duan Z, Meng S. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochem Biophys Res Commun 2010; 398: 771-777 [PMID: 20633528 DOI: 10.1016/j. bbrc.2010.07.021]
48. Protzer U, Seyfried S, Quasdorff M, Sass G, Svorcova M, Webb D, Bohne F, Hösel M, Schirmacher P, Tiegs G. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology 2007; 133: 1156-1165 [PMID: 17919491 DOI: 10.1053/ j. gastro.2007.07.021]
49. Ji F, Yang B, Peng X, Ding H, You H, Tien P. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat 2011; 18: e242-e251 [PMID: 21692939 DOI: 10.1111/ j.1365-2893.2011.01443. x]
50. Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 2007; 13: 1241-1247 [PMID: 17906637 DOI: 10.1038/nm1639]
51. Otsuka M, Jing Q, Georgel P, New L, Chen J, Mols J, Kang YJ, Jiang Z, Du X, Cook R, Das SC, Pattnaik AK, Beutler B, Han J. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 2007; 27: 123-134 [PMID: 17613256 DOI: 10.1016/j. immuni.2007.05.014]
52. Pfeffer S, Zavolan M, Grässer FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T. Identification of virus-encoded microRNAs. Science 2004; 304: 734-736 [PMID: 15118162 DOI: 10.1126/science.1096781]
53. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, Kremmer E, Jäker C, Höck J, Meister G, Grässer FA. Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 2008; 36: 666-675 [PMID: 18073197 DOI: 10.1093/nar/gkm1080]
54. Lo AK, To KF, Lo KW, Lung RW, Hui JW, Liao G, Hayward SD. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci USA 2007; 104: 16164-16169 [PMID: 17911266 DOI: 10.1073/ pnas.0702896104]
55. Jin WB, Wu FL, Kong D, Guo AG. HBV-encoded microRNA candidate and its target. Comput Biol Chem 2007; 31: 124-126 [PMID: 17350341 DOI: 10.1016/j. compbiolchem.2007.01.005]
56. Liu WH, Yeh SH, Chen PJ. Role of microRNAs in hepatitis B virus replication and pathogenesis. Biochim Biophys Acta 2011; 1809: 678-685 [PMID: 21565290 DOI: 10.1016/ j. bbagrm.2011.04.008]
57. Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, Chen PJ. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 2009; 50: 1392-1402 [PMID: 19670412 DOI: 10.1002/hep.23163]
58. Buhlmann S, Racek T, Schwarz A, Schaefer S, Pützer BM. Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: implications for hepatocarcinogenesis. J Mol Biol 2008; 378: 20-30 [PMID: 18342333 DOI: 10.1016/j. jmb.2008.02.021]
59. Lee GH, Wasser S, Lim SG. Hepatitis B pregenomic RNA splicing--the products, the regulatory mechanisms and its biological significance. Virus Res 2008; 136: 1-7 [PMID: 18579251 DOI: 10.1016/j. virusres.2008.05.007]
60. Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res 2010; 88: 169-175 [PMID: 20728471 DOI: 10.1016/j. antiviral.2010.08.008]
61. Potenza N, Papa U, Mosca N, Zerbini F, Nobile V, Russo A. Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res 2011; 39: 5157-5163 [PMID: 21317190 DOI: 10.1093/nar/ gkr067]
62. Braconi C, Huang N, Patel T. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 2010; 51: 881-890 [PMID: 20146264 DOI: 10.1002/hep.23381]
63. Huang J, Wang Y, Guo Y, Sun S. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 2010; 52: 60-70 [PMID: 20578129 DOI: 10.1002/hep.23660]
64. Zhang X, Zhang E, Ma Z, Pei R, Jiang M, Schlaak JF, Roggendorf M, Lu M. Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1. Hepatology 2011; 53: 1476-1485 [PMID: 21520166 DOI: 10.1002/ hep.24195]
65. Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X, Wu Z. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Cell Signal 2013; 25: 439-446 [PMID: 23124077 DOI: 10.1016/j. cellsig.2012.10.013]
66. Ren M, Qin D, Li K, Qu J, Wang L, Wang Z, Huang A, Tang H. Correlation between hepatitis B virus protein and microRNA processor Drosha in cells expressing HBV. Antiviral Res 2012; 94: 225-231 [PMID: 22554933 DOI: 10.1016/ j. antiviral.2012.04.004]
67. Waidmann O, Bihrer V, Pleli T, Farnik H, Berger A, Zeuzem S, Kronenberger B, Piiper A. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J Viral Hepat 2012; 19: e58-e65 [PMID: 22239527 DOI: 10.1111/j.1365-2893.2011.01536. x]
68. Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K, Kaneko S. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009; 49: 1098-1112 [PMID: 19173277 DOI: 10.1002/hep.22749]
69. Tomimaru Y, Eguchi H, Nagano H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Tomokuni A, Takemasa I, Umeshita K, Kanto T, Doki Y, Mori M. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol 2012; 56: 167-175 [PMID: 21749846 DOI: 10.1016/ j. jhep.2011.04.026]
70. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, Tian W, Zhang Q, Wang C, Zhang Q, Zhuang SM, Zheng L, Liang A, Tao W, Cao X. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011; 19: 232-243 [PMID: 21316602 DOI: 10.1016/j. ccr.2011.01.001]
71. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi M, Tacke F, Trautwein C, Luedde T. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011; 53: 209-218 [PMID: 20890893 DOI: 10.1002/hep.23922]
72. Ogawa T, Enomoto M, Fujii H, Sekiya Y, Yoshizato K, Ikeda K, Kawada N. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut 2012; 61: 1600-1609 [PMID: 22267590 DOI: 10.1136/gutjnl-2011-300717]
73. Lakner AM, Steuerwald NM, Walling TL, Ghosh S, Li T, McKillop IH, Russo MW, Bonkovsky HL, Schrum LW. Inhibitory effects of microRNA 19b in hepatic stellate cellmediated fibrogenesis. Hepatology 2012; 56: 300-310 [PMID: 22278637 DOI: 10.1002/hep.25613]
74. Gao P, Wong CC, Tung EK, Lee JM, Wong CM, Ng IO. Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J Hepatol 2011; 54: 1177-1184 [PMID: 21145831 DOI: 10.1016/j. jhep.2010.09.023]
75. Zhang X, Liu S, Hu T, Liu S, He Y, Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009; 50: 490-499 [PMID: 19472311 DOI: 10.1002/hep.23008]
76. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866 [PMID: 17060945 DOI: 10.1038/nrc1997]
77. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006 [PMID: 18766170 DOI: 10.1038/ cr.2008.282]
78. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518 [PMID: 18663219 DOI: 10.1073/ pnas.0804549105]
79. Shabaneh Al-Tamimi HA, McDonald R. Elevated alanine aminotransferase levels associated with polymyositis: can this be due to muscle injury? J Clin Rheumatol 2008; 14: 363-364 [PMID: 19033872 DOI: 10.1097/ RHU.0b013e318190b4a6]
80. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. The current state of serum biomarkers of hepatotoxicity. Toxicology 2008; 245: 194-205 [PMID: 18291570 DOI: 10.1016/ j. tox.2007.11.021]
81. Nathwani RA, Pais S, Reynolds TB, Kaplowitz N. Serum alanine aminotransferase in skeletal muscle diseases. Hepatology 2005; 41: 380-382 [PMID: 15660433 DOI: 10.1002/ hep.20548]
82. Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 2008; 47: 1363-1370 [PMID: 18366115 DOI: 10.1002/hep.22109]
83. Amacher DE, Adler R, Herath A, Townsend RR. Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy. Clin Chem 2005; 51: 1796-1803 [PMID: 16099942 DOI: 10.1373/ clinchem.2005.049908]
84. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H, Fei M, Sun S. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010; 56: 1830-1838 [PMID: 20930130 DOI: 10.1373/ clinchem.2010.147850]
85. Marrero JA, Lok AS. Newer markers for hepatocellular carcinoma. Gastroenterology 2004; 127: S113-S119 [PMID: 15508074]
86. Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Takasaki K, Takenami K, Yamamoto M, Nakano M. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma. Cancer 2000; 88: 544-549 [PMID: 10649245]
87. Hayes CN, Akamatsu S, Tsuge M, Miki D, Akiyama R, Abe H, Ochi H, Hiraga N, Imamura M, Takahashi S, Aikata H, Kawaoka T, Kawakami Y, Ohishi W, Chayama K. Hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycle. PLoS One 2012; 7: e47490 [PMID: 23091627 DOI: 10.1371/journal. pone.0047490]
88. Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, Wang JF, Zhang Z, Lu S, Huang X, Wang Z, Qiu S, Wang X, Yang G, Sun H, Tang Z, Wu Y, Zhu H, Fan J. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 2011; 29: 4781-4788 [PMID: 22105822 DOI: 10.1200/jco.2011.38.2697]
89. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, Tang ZY, Wang XW. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008; 47: 897-907 [PMID: 18176954 DOI: 10.1002/hep.22160]
90. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, Roberts LR, Schmittgen TD. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008; 14: 419-427 [PMID: 18223217 DOI: 10.1158/1078-0432. ccr-07-0523]
91. Li W, Xie L, He X, Li J, Tu K, Wei L, Wu J, Guo Y, Ma X, Zhang P, Pan Z, Hu X, Zhao Y, Xie H, Jiang G, Chen T, Wang J, Zheng S, Cheng J, Wan D, Yang S, Li Y, Gu J. Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 2008; 123: 1616-1622 [PMID: 18649363 DOI: 10.1002/ijc.23693]
92. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY, Zen K. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBVpositive hepatocarcinoma. Cancer Res 2010; 70: 9798-9807 [PMID: 21098710 DOI: 10.1158/0008-5472. can-10-1001]
93. Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 2011; 6: e28486 [PMID: 22174818 DOI: 10.1371/ journal. pone.0028486]
94. Chen CJ, Lee MH. Early diagnosis of hepatocellular carcinoma by multiple microRNAs: validity, efficacy, and cost-effectiveness. J Clin Oncol 2011; 29: 4745-4747 [PMID: 22105818 DOI: 10.1200/jco.2011.39.0054]
95. Cai G, Liu Y. Diagnosing advanced versus early-stage hepatocellular carcinoma. J Clin Oncol 2012; 30: 2167; author reply 2168 [PMID: 22564987 DOI: 10.1200/jco.2011.41.3641]
96. Gao YF, Yu L, Wei W, Li JB, Luo QL, Shen JL. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA. World J Gastroenterol 2008; 14: 4684-4689 [PMID: 18698684]
97. Ebert G, Poeck H, Lucifora J, Baschuk N, Esser K, Esposito I, Hartmann G, Protzer U. 5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice. Gastroenterology 2011; 141: 696-706, 706. e1-3 [PMID: 21684282 DOI: 10.1053/j. gastro.2011.05.001]
98. McCaffrey AP. RNA interference inhibitors of hepatitis B virus. Ann N Y Acad Sci 2009; 1175: 15-23 [PMID: 19796073 DOI: 10.1111/j.1749-6632.2009.04974. x]
99. Brown BD, Naldini L. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat Rev Genet 2009; 10: 578-585 [PMID: 19609263 DOI: 10.1038/nrg2628]
100. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006; 441: 537-541 [PMID: 16724069 DOI: 10.1038/nature04791]
101. Arbuthnot P. MicroRNA-like antivirals. Biochim Biophys Acta 2011; 1809: 746-755 [PMID: 21616187 DOI: 10.1016/ j. bbagrm.2011.05.006]
102. Keck K, Volper EM, Spengler RM, Long DD, Chan CY, Ding Y, McCaffrey AP. Rational design leads to more potent RNA interference against hepatitis B virus: factors effecting silencing efficiency. Mol Ther 2009; 17: 538-547 [PMID: 19088704 DOI: 10.1038/mt.2008.273]
103. Ely A, Naidoo T, Mufamadi S, Crowther C, Arbuthnot P. Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo. Mol Ther 2008; 16: 1105-1112 [PMID: 18431360 DOI: 10.1038/mt.2008.82]
104. Chattopadhyay S, Ely A, Bloom K, Weinberg MS, Arbuthnot P. Inhibition of hepatitis B virus replication with linear DNA sequences expressing antiviral micro-RNA shuttles. Biochem Biophys Res Commun 2009; 389: 484-489 [PMID: 19733548 DOI: 10.1016/j. bbrc.2009.09.004]
105. Xiangji L, Feng X, Qingbao C, Weifeng T, Xiaoqing J, Baihe Z, Feng S, Hongyang W, Mengchao W. Knockdown of HBV surface antigen gene expression by a lentiviral microRNAbased system inhibits HBV replication and HCC growth. J Viral Hepat 2011; 18: 653-660 [PMID: 20642484 DOI: 10.1111/ j.1365-2893.2010.01346. x]